Design and development of galantamine hydrobromide transdermal patch for treatment of alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disease, which is caused by abnormal accumulation of beta amyloid (Aβ) peptide in brain and degeneration of cholinergic neurons. Galantamine hydrobromide (GH) is an effective drug for the treatment of AD with its function as the acetylcholinesterase en...
| Autor principal: | |
|---|---|
| Formato: | Thesis |
| Idioma: | English |
| Publicado em: |
2015
|
| Acesso em linha: | http://psasir.upm.edu.my/id/eprint/65408/1/FS%202015%2045IR.pdf |